Innovation Ventures Search Results
Narrow Your Results
Filter
Technology PatentStatus
- All (7)
- Issued Patent (0)
- National Phase Entry (0)
- PCT Filing (2)
- Provisional Filing (2)
- US Non-Provisional Filing (3)
Technology Categories
- All (7)
- Diagnostics (2)
- Educational Tools and Consumer Products (0)
- Medical Devices (0)
- Other (0)
- Research Tools (0)
- Software (0)
- Therapeutics (5)
Technology Stage Of Development
- All Results (5)
- Cell and Gene Therapy (1)
- Organoids (0)
- Other Biologics and Macromolecules (2)
- Small Molecule (2)
- Vaccines (1)
Results (7)
CAR-NK Therapy for Lupus
Human Natural Killer cells expressing chimeric antigen receptor that targets aberrant immune system signaling that is involved in auto-antibody production associated with Systemic Lupus Erythematosus.
Methods for treating inflammation and autoimmune disease.
Methods for treating inflammation and autoimmune disease.
Non-Invasive Eosinophilic Gastritis Diagnostic
Non-Invasive Eosinophilic Gastritis Diagnostic
Non-invasive diagnostic test for Eosinophilic Esophagitis
A non-invasive method for Eosinophilic diagnosis and monitoring using buccal membrane biomarkers
Serine Protease Inhibitors (SPINK7) for Treatment of EoE
Deficiency of SPINK7 is a novel regulator of pro-inflammatory cytokine production in eosinophilic esophagitis.
Small molecule perforin inhibitors to enhance vaccine efficacy
Perforin inhibition during vaccination can improve vaccine success against a variety of infections and diseases for which sufficiently efficacious immune response has proven difficult
Targeting NTRK1 for Treatment of Allergic Inflammatory Conditions
Pharmacological targeting of NTRK1 using small molecule inhibitors may reduce allergic inflammation.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
